Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
House dust mite subcutaneous immunotherapy in children with allergic rhinitis with and without asthma
TCTR20260829005Phase 3Recruiting
- Sponsor
- Ministry of Finance
- Start
- Feb 2025
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of dermatophagoides pteronyssinus in allergic rhinitis (AR), asthma, sponsored by Ministry of Finance. Started Feb 2025; status: recruiting.
02
Drugs
dermatophagoides pteronyssinus
03
Conditions
allergic rhinitis (AR)asthma
Beyond the preview
Go deeper on TCTR20260829005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260829005.